Disease | hepatitis |
Phenotype | C0021831|bowel disease |
Sentences | 12 |
PubMedID- 20848488 | hepatitis b reactivation in patients with inflammatory bowel disease: a prospective survey on screening and prevention practices at general hospitals in france. |
PubMedID- 21892694 | Azathioprine induced hepatitis in patients with inflammatory bowel disease. |
PubMedID- 23354318 | Improving care for inflammatory bowel disease patients infected with hepatitis b virus. |
PubMedID- 25160690 | Immunogenicity of hepatitis b vaccine in patients with inflammatory bowel disease and the benefits of revaccination. |
PubMedID- 25957555 | Chronic bowel disease can co-exist with severe autoimmune hepatitis (aih) in an absence of primary sclerosing cholangitis. |
PubMedID- 25386085 | hepatitis b vaccination in patients with inflammatory bowel disease. |
PubMedID- 22530631 | Comparison of the effectiveness of two protocols for vaccination (standard and double dosage) against hepatitis b virus in patients with inflammatory bowel disease. |
PubMedID- 23664999 | Factors predicting response to hepatitis b vaccination in patients with inflammatory bowel disease. |
PubMedID- 24162170 | Prevalence of hepatitis-b viral markers in patients with inflammatory bowel disease in a hepatitis-b-endemic area: inadequate protective antibody levels in young patients. |
PubMedID- 23891915 | Efficacy and safety of treatment of hepatitis c in patients with inflammatory bowel disease. |
PubMedID- 26039133 | Evaluation of factors associated with response to hepatitis b vaccination in patients with inflammatory bowel disease. |
PubMedID- 20688604 | Background: data on the prevalence of hepatitis c in patients with inflammatory bowel diseases (ibd) are limited and conflicting. |
Page: 1